Lili Sun
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Chidamide and venetoclax synergistically regulate the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL.
Journal: Annals of hematology
Published: October 16, 2024
Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 06, 2023
Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia.
Journal: Molecular biology reports
Published: April 11, 2023
A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia.
Journal: Journal of translational medicine
Published: December 19, 2020
Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL.
Journal: Investigational new drugs
Published: November 27, 2020
Growth inhibition and suppression of the mTOR and Wnt/β-catenin pathways in T-acute lymphoblastic leukemia by rapamycin and MYCN depletion.
Journal: Hematological oncology
Published: September 01, 2020
Integrating microRNA and mRNA expression in rapamycin-treated T-cell acute lymphoblastic leukemia.
Journal: Pathology, research and practice
Published: April 14, 2019
Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration.
Journal: Journal of translational medicine
Published: September 01, 2018
MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3.
Journal: Journal of cellular and molecular medicine
Published: November 27, 2017
Last Updated: 09/26/2026